• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经动脉化疗栓塞治疗肝细胞癌反应的影像学预测因素:放射病理学相关性研究。

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.

机构信息

Department of Radiology, University of Washington, Seattle, WA, USA.

出版信息

Liver Transpl. 2012 Jun;18(6):727-36. doi: 10.1002/lt.23413.

DOI:10.1002/lt.23413
PMID:22344899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4161220/
Abstract

Transarterial chemoembolization (TACE) is one of the standard therapies for bridging patients with hepatocellular carcinoma (HCC) to transplantation. This study was designed to determine which features on pre- and post-TACE imaging are associated with tumor necrosis in pathological specimens. Records of 105 patients with 132 HCC lesions who underwent liver transplantation after TACE were retrospectively reviewed. In 70% of the nodules, >90% necrosis was achieved. The development of >90% lesion necrosis upon pathological analysis was associated with avid lesion enhancement (P = 0.03) and the presence of a feeding vessel larger than 0.9 mm in diameter on the pre-TACE visceral angiogram (P = 0.01). Near-complete lesion necrosis was also associated with an extensive accumulation of ethiodized oil within a lesion during TACE administration (P = 0.04). On post-TACE computed tomography imaging, a lack of residual contrast enhancement (P < 0.0001), a decrease in the lesion size (P = 0.04), a high lesion density due to an accumulation of ethiodized oil (P = 0.03), and a diffuse distribution of ethiodized oil throughout the lesion (P = 0.0001) were also correlated with near-complete lesion necrosis upon pathological analysis. In conclusion, this study found multiple pre- and post-TACE imaging characteristics of HCC that were associated with near-complete tumor necrosis upon histopathological analysis after TACE. These findings may help to guide the selection of an optimal treatment strategy for bridging patients with HCC to liver transplantation.

摘要

经动脉化疗栓塞术(TACE)是将肝细胞癌(HCC)患者桥接至肝移植的标准治疗方法之一。本研究旨在确定 TACE 前后影像学上的哪些特征与病理标本中的肿瘤坏死有关。回顾性分析了 105 例接受 TACE 后行肝移植的 132 个 HCC 病变患者的记录。在 70%的结节中,达到了>90%的坏死。病理分析显示>90%的病变坏死与病灶增强明显(P=0.03)和 TACE 内脏血管造影前直径>0.9 毫米的供养血管存在(P=0.01)有关。近完全的病变坏死也与 TACE 过程中病变内碘化油的广泛积聚有关(P=0.04)。在 TACE 后 CT 成像上,缺乏残留的对比增强(P<0.0001)、病变大小减小(P=0.04)、由于碘化油积聚导致的病变密度增加(P=0.03)和碘化油在整个病变中的弥漫分布(P=0.0001)也与病理分析上的近完全病变坏死有关。总之,本研究发现了多个 HCC 的 TACE 前后影像学特征,这些特征与 TACE 后组织病理学分析中的近完全肿瘤坏死有关。这些发现可能有助于指导为 HCC 患者选择最佳的桥接治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/af7c670c54d3/nihms356500f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/58c1fadb5a36/nihms356500f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/c511a07a310f/nihms356500f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/af7c670c54d3/nihms356500f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/58c1fadb5a36/nihms356500f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/c511a07a310f/nihms356500f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d21c/4161220/af7c670c54d3/nihms356500f3.jpg

相似文献

1
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.经动脉化疗栓塞治疗肝细胞癌反应的影像学预测因素:放射病理学相关性研究。
Liver Transpl. 2012 Jun;18(6):727-36. doi: 10.1002/lt.23413.
2
Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation.肝癌的放射学表现可预测行肝移植患者接受经动脉化疗栓塞治疗的反应。
BMC Cancer. 2019 Nov 5;19(1):1041. doi: 10.1186/s12885-019-6265-1.
3
Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.基于 MRI 容积增强和 CT 容积油沉积与病理相关性预测肝癌 TACE 后坏死。
Eur Radiol. 2018 Jul;28(7):3032-3040. doi: 10.1007/s00330-017-5198-9. Epub 2018 Jan 30.
4
C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.C形臂碘油CT在小肝细胞癌经动脉化疗栓塞术中的应用
World J Gastroenterol. 2015 Mar 14;21(10):3035-40. doi: 10.3748/wjg.v21.i10.3035.
5
Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.TACE术后肝癌的多层螺旋CT与组织形态学的相关性:预后预测因素
Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):768-77. doi: 10.1007/s00270-007-9270-8. Epub 2008 Jan 15.
6
Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.计算机断层扫描灌注成像在评估经动脉化疗栓塞治疗肝细胞癌疗效中的应用
World J Gastroenterol. 2008 Oct 7;14(37):5738-43. doi: 10.3748/wjg.14.5738.
7
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.经动脉化疗栓塞术治疗前行肝移植的患者,其放射学反应和炎症评分可预测肿瘤复发。
World J Gastroenterol. 2017 May 28;23(20):3690-3701. doi: 10.3748/wjg.v23.i20.3690.
8
Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.经动脉化疗栓塞联合多影像引导下射频消融治疗直径3.1至5.0厘米的肝细胞癌结节:一项单中心研究
J Int Med Res. 2018 Jul;46(7):2650-2657. doi: 10.1177/0300060518768420. Epub 2018 Apr 23.
9
Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.基于双期增强 CT 图像数据的纹理分析参数评价在药物洗脱微球经导管动脉化疗栓塞术(DEB-TACE)治疗肝细胞癌患者中的疗效预测:与肝灌注 CT 的相关性。
Acad Radiol. 2017 Nov;24(11):1352-1363. doi: 10.1016/j.acra.2017.05.006. Epub 2017 Jun 23.
10
Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.经动脉化疗栓塞术后18氟脱氧葡萄糖正电子发射断层扫描对接受原位肝移植的肝细胞癌患者的预后价值
Transplant Proc. 2015 Oct;47(8):2374-6. doi: 10.1016/j.transproceed.2015.08.026.

引用本文的文献

1
A network meta-analysis of different interventional treatment strategies for unresectable hepatocellular carcinoma.不可切除肝细胞癌不同介入治疗策略的网状Meta分析
BMC Gastroenterol. 2025 May 12;25(1):360. doi: 10.1186/s12876-025-03980-2.
2
LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features.LI-RADS 版本 2018 经动脉化疗栓塞治疗肝细胞癌患者的细胞外对比增强 MRI 治疗反应算法:诊断性能和辅助特征的附加价值。
Abdom Radiol (NY). 2024 Sep;49(9):3045-3055. doi: 10.1007/s00261-024-04275-y. Epub 2024 Apr 11.
3
Preoperative Balloon-Occluded Transcatheter Arterial Chemoembolization Followed by Surgical Resection: Pathological Evaluation of Necrosis.术前球囊闭塞经导管动脉化疗栓塞术联合手术切除:坏死的病理评估
Diseases. 2023 Oct 24;11(4):149. doi: 10.3390/diseases11040149.
4
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.碘化油作为常规经动脉化疗栓塞后的成像生物标志物。
Eur Radiol. 2024 May;34(5):3284-3297. doi: 10.1007/s00330-023-10326-7. Epub 2023 Nov 6.
5
Local Recurrence following Radiological Complete Response in Patients Treated with Subsegmental Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.肝细胞癌患者接受节段性球囊阻断经导管动脉化疗栓塞术后影像学完全缓解后的局部复发
Cancers (Basel). 2023 Oct 14;15(20):4991. doi: 10.3390/cancers15204991.
6
Concerns about how to simultaneously determine microvascular invasion and pathological response after transarterial chemoembolization before hepatocellular carcinoma surgery.关于如何在肝细胞癌手术前同时确定经动脉化疗栓塞术后的微血管侵犯和病理反应的问题。
Hepatobiliary Surg Nutr. 2023 Oct 1;12(5):815-817. doi: 10.21037/hbsn-23-443. Epub 2023 Sep 18.
7
Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment.评估肝细胞癌局部区域治疗后的治疗反应:可用的血清学和影像学评估工具综述
JGH Open. 2023 Apr 3;7(4):249-260. doi: 10.1002/jgh3.12879. eCollection 2023 Apr.
8
Microwave ablation as a primary versus secondary treatment for hepatocellular carcinoma.微波消融作为原发性与继发性肝癌的治疗方法。
Diagn Interv Radiol. 2023 Mar 29;29(2):359-366. doi: 10.4274/dir.2023.221930. Epub 2023 Mar 1.
9
Balloon-occluded transarterial chemoembolization versus conventional transarterial chemoembolization for the treatment of single hepatocellular carcinoma: a propensity score matching analysis.球囊阻断经动脉化疗栓塞与常规经动脉化疗栓塞治疗单个肝细胞癌的疗效比较:倾向评分匹配分析。
Eur Radiol. 2023 Apr;33(4):2655-2664. doi: 10.1007/s00330-022-09284-3. Epub 2022 Dec 6.
10
Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma.肝细胞癌完全病理缓解的肝移植受者中肿瘤标志物的表达模式
J Clin Med. 2022 Oct 6;11(19):5897. doi: 10.3390/jcm11195897.

本文引用的文献

1
Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas.选择性经动脉化疗栓塞术诱导小(<5cm)肝癌肿瘤坏死的疗效。
Hepatology. 2011 May;53(5):1580-9. doi: 10.1002/hep.24246.
2
Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization.经化疗栓塞治疗的肝细胞癌的放射病理相关性。
Cardiovasc Intervent Radiol. 2010 Dec;33(6):1143-52. doi: 10.1007/s00270-009-9766-5. Epub 2009 Dec 5.
3
Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.终末期肝病模型对经动脉化疗栓塞治疗的肝细胞癌患者生存预测的价值。
Scand J Gastroenterol. 2009;44(3):346-57. doi: 10.1080/00365520802530838.
4
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.肝移植前肝细胞癌降期后的良好预后:一项意向性分析。
Hepatology. 2008 Sep;48(3):819-27. doi: 10.1002/hep.22412.
5
Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.TACE术后肝癌的多层螺旋CT与组织形态学的相关性:预后预测因素
Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):768-77. doi: 10.1007/s00270-007-9270-8. Epub 2008 Jan 15.
6
Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.肝细胞癌的动脉血供与组织学分级:影像学-病理学相关性
AJR Am J Roentgenol. 2008 Jan;190(1):W28-34. doi: 10.2214/AJR.07.2117.
7
Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.在进行桥接治疗后肝移植肝切除标本中肿瘤完全坏死的肝细胞癌患者的疾病进程。
Eur J Med Res. 2005 Dec 7;10(12):539-42.
8
Resection and liver transplantation for hepatocellular carcinoma.肝细胞癌的切除术与肝移植术
Semin Liver Dis. 2005;25(2):181-200. doi: 10.1055/s-2005-871198.
9
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
10
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.肝细胞癌结节中的部分坏死会促使肝移植后肿瘤复发。
Transplantation. 2004 Dec 27;78(12):1780-6. doi: 10.1097/01.tp.0000145892.97114.ee.